In Ovations Holdings, Inc. announced the implementation of the technology using sputum cytology for the early detection of lung cancer, a recognized laboratory procedure similar to the 'Pap' test.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -99.00% | -.--% | -.--% |
2017 | In Ovations Holdings, Inc. Appoints Kenneth Hughes as Chief Science Officer | CI |
2017 | In Ovations Holdings, Inc. Announces Resignation of Rosendo Alvarez III as Officer and Director | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 5.56K | |
+9.89% | 67.2B | |
+11.66% | 18.21B | |
+19.20% | 13.23B | |
+6.43% | 13.01B | |
+15.83% | 9.91B | |
-26.30% | 6.32B | |
-9.80% | 5.65B | |
-2.46% | 4.99B | |
-2.66% | 4.88B |
- Stock Market
- Equities
- INOH Stock
- News In Ovations Holdings, Inc.
- In Ovations Holdings, Inc. Announces the Availability of the Early Detection of Lung Cancer Kit